Cover Image
市場調查報告書

南美的醫藥品、醫療產業 (季度更新)

Latin America Pharmaceuticals and Healthcare Report Q2 2017

出版商 BMI Research 商品編碼 362186
出版日期 內容資訊 英文 35 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
南美的醫藥品、醫療產業 (季度更新) Latin America Pharmaceuticals and Healthcare Report Q2 2017
出版日期: 2017年04月26日 內容資訊: 英文 35 Pages
簡介

本報告提供南美的到醫藥品、醫療產業調查分析,到2025年的10年預測為焦點,產業分析,產業預測,產業風險/利潤指數 (RRI) 、市場概要,產業趨勢,各地區的概要等系統性資訊。

BMI的產業分析

SWOT

產業預測

  • 醫藥品市場預測
  • 醫療市場預測

產業風險/利潤指數 (RRI)

  • 南北美洲的RRI

市場概要

產業趨勢與發展

  • 產業趨勢與發展

各地區的概要

詞彙表

調查手法

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: 2398-1032

BMI View: The deteriorating political and economic outlook in Latin America is increasing the risks to multinational drugmakers' regional growth. For example, the increasing likelihood of a sovereign default in Venezuela will degrade the country's operating environment and impact multinational drugmakers' regional performance. NAFTA renegotiation also poses downside risks for the Mexican pharmaceutical sector with the potential for prolonged weakness in the Mexican peso, protectionist trade measures and restricted foreign direct investment. Nonetheless, government commitment to healthcare in Latin America remains a positive for long-term prospects, with the expansion of public medical services to provide significant commercial opportunities.

Headline Expenditure Projections

  • Pharmaceuticals: USD62.5bn in 2016 to USD63.7bn in 2017; 2.0% in US dollar terms.
  • Healthcare: USD379.1bn in 2016 to USD400.2bn in 2017; 5.6% in US dollar terms.

Risk/Reward Index

The Americas region will remain characterised by highly divergent levels of attractiveness for innovative pharmaceutical firms. While North America presents considerable opportunities for the commercialisation of pharmaceuticals, it is vital that companies appreciate the varying levels of investment risks and rewards that are present in the emerging markets of Latin America. BMI's Innovative Pharmaceuticals Risk/Reward Index tool, which provides a globally comparative and numerically based assessment of a market's attractiveness for companies looking to launch a high-value drug, was established to address this.

Table of Contents

BMI Industry View

  • Latin America - Q2 2017
    • Table: Headline Pharmaceuticals & Healthcare Forecasts ( Latin America ( Latin America (Region) 2015-2021)

SWOT

  • Latin America - Q2 2017

Industry Forecast

  • Pharmaceutical - Latin America - Q2 2017
    • Table: Regional Pharmaceuticals Sales, Historical Data & Forecasts (2014-2020)
  • Healthcare - Latin America - Q2 2017
    • Table: Regional Healthcare Sales, Historical Data & Forecasts (2013-2021)

Industry Risk/Reward Index

  • Americas Risk/Reward Index - Q2 2017

Market Overview

  • Latin America - Q2 2017

Industry Trend And Developments

  • Regional Themes - Latin America - Q2 2017

Regional Overview

  • Regional Round-up - Q2 2017

Glossary

Methodology

  • Pharmaceutical Expenditure Forecast Model
  • Healthcare Expenditure Forecast Model
  • Notes On Methodology
  • Risk/Reward Index Methodology
    • Table: Indicators - Rationale And Sources
Back to Top